Literature DB >> 25753514

Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study.

Lu Li1, Yan Wu1, Li Li1, Yan Sun1, Li Qiu1, Xing-Hua Gao1, Hong-Duo Chen1.   

Abstract

Vitiligo on extremities and/or bony prominences is very resistant to treatment. Twenty-five patients with symmetrical and stable vitiligo on extremities and/or bony prominences were enrolled. The treatment side received fractional carbon dioxide laser followed by topical compound betamethasone solution and narrowband ultraviolet B phototherapy. The control side received laser treatment plus phototherapy. The result of treatment side showed that 44% patients achieved over 50% re-pigmentation and patient satisfaction score was 5.12 ± 3.23, higher than those of control (p < 0.05). Adverse events were slight and tolerable. The triple combination treatment could be used as an alternative modality for refractory vitiligo.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  laser; therapy-topical; vitiligo

Mesh:

Substances:

Year:  2015        PMID: 25753514     DOI: 10.1111/dth.12202

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  9 in total

1.  Fractional Er:YAG laser assisting topical betamethasone solution in combination with NB-UVB for resistant non-segmental vitiligo.

Authors:  Ru Yan; Jinping Yuan; Hongqiang Chen; Yuan-Hong Li; Yan Wu; Xing-Hua Gao; Hong-Duo Chen
Journal:  Lasers Med Sci       Date:  2017-07-14       Impact factor: 3.161

2.  Effect of combination of fractional CO2 laser and narrow-band ultraviolet B versus narrow-band ultraviolet B in the treatment of non-segmental vitiligo.

Authors:  Mohamed Bakr El-Zawahry; Naglaa Sameh Zaki; Marian Youssry Wissa; Marwah Adly Saleh
Journal:  Lasers Med Sci       Date:  2017-07-26       Impact factor: 3.161

3.  A preliminary study of fractional CO2 laser added to topical tacrolimus combined with 308 nm excimer lamp for refractory vitiligo.

Authors:  Xiang Wen; Michael R Hamblin; Yan Xian; Yong Li
Journal:  Dermatol Ther       Date:  2018-10-11       Impact factor: 2.851

Review 4.  Advances in Vitiligo: An Update on Medical and Surgical Treatments.

Authors:  Alexander B Dillon; Andrew Sideris; Ali Hadi; Nada Elbuluk
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

5.  The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis.

Authors:  Woo Il Kim; Sooyoung Kim; Sang Hoon Lee; Moon Kyun Cho
Journal:  Lasers Med Sci       Date:  2020-06-23       Impact factor: 3.161

6.  A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo.

Authors:  Silada Kanokrungsee; Kumutnart Chanprapaph; Chayada Chaiyabutr; Vasanop Vachiramon
Journal:  Lasers Med Sci       Date:  2016-06-13       Impact factor: 3.161

7.  Platelet-rich plasma versus combined fractional carbon dioxide laser with platelet-rich plasma in the treatment of vitiligo: a comparative study.

Authors:  Mostafa Kadry; Abeer Tawfik; Noha Abdallah; Ashraf Badawi; Hisham Shokeir
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-11-08

8.  Fractional Carbon Dioxide Laser versus Fractional Carbon Dioxide Laser with Autologous Intralesional Platelet-rich Plasma in the Treatment of Stable, Non-segmental Vitiligo: A Randomized Comparative Study.

Authors:  Annie Raizada; Maitreyee Panda; Bhabani Stp Singh; Bikash R Kar
Journal:  J Cutan Aesthet Surg       Date:  2021 Jan-Mar

9.  Effect of vitiligo treatment by compound Glycyrrhizin combined with fractional laser and Triamcinolone Acetonide injection on T Lymphocyte subpopulation.

Authors:  Ling Li; Lei Gao; Yifan Zhao
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.